CDKN2A and sarcoma: The common CNA events in sarcomas including aberrations of the MDM2-p53 and p16-cyclin dependent kinase 4 (CDK4)-retinoblastoma-associated protein pathways, deletion ofTP53 (tumor protein p53),CDKN2A (cyclin dependent kinase inhibitor 2A), as well as chr.